Our future multimodal platform,
available in May 2024, turns data into personalised knowledge.
It is an artificial intelligence platform that deploys machine learning algorithms to analyse data from salivary RNA sequencing and compiles it with other data from other levels of molecular biology, clinical data and data from real-life patient observation and follow-up.
It integrates the clinical trials, cohorts and monitoring systems of Ziwig and its partners.
It provides results from saliva tests such as Ziwig Endotest®, analyses data from clinical trials and cohorts, delivers personalised AI-based advice and services to patients, healthcare professionals and corporate partners.
Our platform will offer digital services directly to patients and the healthcare professionals involved in their care from summer 2024.
Stay connected
Sign up to be notified of the latest news and publications.
